A significant shift in Canadian drug policy has taken place, as the authorities allow the use of psilocybin hallucinogens for therapeutic purposes. Previously, these substances were severely restricted, but a mounting body of evidence suggests they may offer aid for mental health issues like PTSD. This change represents a substantial step toward re